Inventor · disambiguated record
Christian Perigaud
Also filed as: PERIGAUD CHRISTIAN
10 granted patents·297 citations·filing 1996–2018
90Inventor score
Files withIDENIX PHARMACEUTICALS INC3CENTRE NAT RECH SCIENT2CENTRE NAT DE LA RECH SCIENTIFIQUE-CNRS1ISIS PHARMACEUTICALS INC1PEYROTTES SUZANNE1
Top patents by PatentIndex Score
10 records- 0197US7951789B2Compounds and pharmaceutical compositions for the treatment of viral infectionsIDENIX PHARMACEUTICALS INC·Filed 2007·Granted May 31, 2011·92 cites·10 claims
- 0297US7902202B2Compounds and pharmaceutical compositions for the treatment of viral infectionsIDENIX PHARMACEUTICALS INC·Filed 2008·Granted Mar 8, 2011·80 cites·29 claims
- 0396US8691788B2Compounds and pharmaceutical compositions for the treatment of viral infectionsSOMMADOSSI JEAN-PIERRE·Filed 2011·Granted Apr 8, 2014·62 cites·21 claims
- 0488US9249173B2Compounds and pharmaceutical compositions for the treatment of viral infectionsIDENIX PHARMACEUTICALS INC·Filed 2014·Granted Feb 2, 2016·8 cites·23 claims
- 0588US6555676B2Biologically active phosphotriester-type compoundsCENTRE NAT RECH SCIENT·Filed 2001·Granted Apr 29, 2003·24 cites·9 claims
- 0671US5849905ABiologically active phosphotriester-type nucleosides and methods for preparing sameCENTRE NAT RECH SCIENT·Filed 1996·Granted Dec 15, 1998·26 cites·16 claims
- 0763US8614312B2Method for preparing nucleotides and related analogues by synthesis on soluble substrate, and biological tools thus preparedPEYROTTES SUZANNE·Filed 2009·Granted Dec 24, 2013·1 cites·29 claims
- 0858US9783541B25′-nucleotidase inhibitors and therapeutic uses thereofCENTRE NAT DE LA RECH SCIENTIFIQUE-CNRS·Filed 2014·Granted Oct 10, 2017·1 cites·14 claims
- 0948US6399589B1Biologically active phosphotriester-type compoundsISIS PHARMACEUTICALS INC·Filed 1998·Granted Jun 4, 2002·3 cites·3 claims
- 1035US11299506B2Acylnucleoside phosphonates, prodrugs thereof and use thereof as medicamentUNIV MONTPELLIER·Filed 2018·Granted Apr 12, 2022·0 cites·13 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →